Are you Dr. Austin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 36 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
11801 Trailridge Dr
Potomac, MD 20854Phone+1 240-418-5708- Is this information wrong?
Summary
- Dr. Christopher Austin, MD is a board certified neurologist in Potomac, Maryland. He is currently licensed to practice medicine in Maryland, Pennsylvania, and Massachusetts.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1987 - 1990
- Massachusetts General HospitalResidency, Internal Medicine, 1986 - 1987
- Harvard Medical SchoolClass of 1986
Certifications & Licensure
- MD State Medical License 2003 - 2024
- PA State Medical License 1996 - 2006
- MA State Medical License 1990 - 2004
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 24 citationsReport of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.Matthew D. Hall, James M. Anderson, Annaliesa S. Anderson, David Baker, Jay Bradner, Kyle R. Brimacombe, Elizabeth A. Campbell, Kizzmekia S. Corbett, Kara Carter, Sara...> ;The Journal of Infectious Diseases. 2021 Jul 15
- 49 citationsOpportunities and challenges in translational science.Christopher P. Austin> ;Clinical and Translational Science. 2021 Jul 8
- 147 citationsClinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.Tellen D. Bennett, Richard A. Moffitt, Janos Hajagos, Benjamin Amor, Adit Anand, Mark M. Bissell, Katie Rebecca Bradwell, Carolyn Bremer, James Brian Byrd, Alina Denha...> ;JAMA Network Open. 2021 Jul 1
- Join now to see all
Press Mentions
- Feds Now See the Need for Funding Antivirals: TrialSite Will Track the Spend CarefullyJune 18th, 2021
- CURE ID Launched by FDA to Open up Crowdsourcing for Repurposing of Approved Drugs for Novel Uses in Rare DiseaseDecember 9th, 2019
- FDA, NIH's Newest App Asks Clinicians to Log Case Data When Treating Difficult InfectionsDecember 5th, 2019
- Join now to see all